NCT02810275View on ClinicalTrials.gov

Folinic Acid: Supplementation and Therapy

PHASE3CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

September 30, 2013

Conditions
HIV InfectionHCV Coinfection
Interventions
DRUG

Folinic Acid

Folinic acid 5 mg, taking in the morning, daily, during four weeks

DRUG

Placebo

Placebo capsule received 1 tablet, taking in the morning, during four weeks

All Listed Sponsors
collaborator

Universidade Federal de Santa Maria

OTHER

lead

Hospital de Clinicas de Porto Alegre

OTHER

NCT02810275 - Folinic Acid: Supplementation and Therapy | Biotech Hunter | Biotech Hunter